Cargando…

Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients

OBJECTIVES: Evaluation of tumor-infiltrating lymphocytes (TILs) distribution in an Indian cohort of breast cancer patients for its prognostic significance. METHODS: A retrospective cohort of breast cancer patients from a single onco-surgeon’s breast cancer clinic with a uniform treatment strategy wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaid, Pooja M., Puntambekar, Anirudha K., Jumle, Nutan S., Banale, Rituja A., Ansari, Danish, Reddy, Ruhi R., Unde, Rohini R., Namewar, Namrata P., Kelkar, Devaki A., Shashidhara, L. S., Koppiker, Chaitanyanand B., Kulkarni, Madhura D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677664/
https://www.ncbi.nlm.nih.gov/pubmed/36411483
http://dx.doi.org/10.1186/s13000-022-01271-y
_version_ 1784833853895999488
author Vaid, Pooja M.
Puntambekar, Anirudha K.
Jumle, Nutan S.
Banale, Rituja A.
Ansari, Danish
Reddy, Ruhi R.
Unde, Rohini R.
Namewar, Namrata P.
Kelkar, Devaki A.
Shashidhara, L. S.
Koppiker, Chaitanyanand B.
Kulkarni, Madhura D.
author_facet Vaid, Pooja M.
Puntambekar, Anirudha K.
Jumle, Nutan S.
Banale, Rituja A.
Ansari, Danish
Reddy, Ruhi R.
Unde, Rohini R.
Namewar, Namrata P.
Kelkar, Devaki A.
Shashidhara, L. S.
Koppiker, Chaitanyanand B.
Kulkarni, Madhura D.
author_sort Vaid, Pooja M.
collection PubMed
description OBJECTIVES: Evaluation of tumor-infiltrating lymphocytes (TILs) distribution in an Indian cohort of breast cancer patients for its prognostic significance. METHODS: A retrospective cohort of breast cancer patients from a single onco-surgeon’s breast cancer clinic with a uniform treatment strategy was evaluated for TILs. Tumor sections were H&E stained and scored for the spatial distribution and percent stromal TILs infiltration by a certified pathologist. The scores were analysed for association with treatment response and survival outcomes across molecular subtypes. RESULTS: Total 229 breast cancer tumors were evaluated. Within spatial distribution categories, intra-tumoral TILs were observed to be associated with complete pathological response and lower recurrence frequency for the entire cohort. Subtype-wise analysis of stromal TILs (sTILs) re-enforced significantly higher infiltration in TNBC compared to HER2-positive and ER-positive tumors. A favourable association of higher stromal infiltration was observed with treatment response and disease outcomes, specifically in TNBC. CONCLUSION: Intra-tumoral TILs showed a higher proportion with favourable association with better patient outcomes in an Indian cohort, unlike western cohorts where both stromal and intra-tumoral TILs show similar association with prognosis. With further validation, TILs can be developed as a cost-effective surrogate marker for treatment response, especially in a low-resource setting such as India. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13000-022-01271-y.
format Online
Article
Text
id pubmed-9677664
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96776642022-11-22 Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients Vaid, Pooja M. Puntambekar, Anirudha K. Jumle, Nutan S. Banale, Rituja A. Ansari, Danish Reddy, Ruhi R. Unde, Rohini R. Namewar, Namrata P. Kelkar, Devaki A. Shashidhara, L. S. Koppiker, Chaitanyanand B. Kulkarni, Madhura D. Diagn Pathol Research OBJECTIVES: Evaluation of tumor-infiltrating lymphocytes (TILs) distribution in an Indian cohort of breast cancer patients for its prognostic significance. METHODS: A retrospective cohort of breast cancer patients from a single onco-surgeon’s breast cancer clinic with a uniform treatment strategy was evaluated for TILs. Tumor sections were H&E stained and scored for the spatial distribution and percent stromal TILs infiltration by a certified pathologist. The scores were analysed for association with treatment response and survival outcomes across molecular subtypes. RESULTS: Total 229 breast cancer tumors were evaluated. Within spatial distribution categories, intra-tumoral TILs were observed to be associated with complete pathological response and lower recurrence frequency for the entire cohort. Subtype-wise analysis of stromal TILs (sTILs) re-enforced significantly higher infiltration in TNBC compared to HER2-positive and ER-positive tumors. A favourable association of higher stromal infiltration was observed with treatment response and disease outcomes, specifically in TNBC. CONCLUSION: Intra-tumoral TILs showed a higher proportion with favourable association with better patient outcomes in an Indian cohort, unlike western cohorts where both stromal and intra-tumoral TILs show similar association with prognosis. With further validation, TILs can be developed as a cost-effective surrogate marker for treatment response, especially in a low-resource setting such as India. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13000-022-01271-y. BioMed Central 2022-11-21 /pmc/articles/PMC9677664/ /pubmed/36411483 http://dx.doi.org/10.1186/s13000-022-01271-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Vaid, Pooja M.
Puntambekar, Anirudha K.
Jumle, Nutan S.
Banale, Rituja A.
Ansari, Danish
Reddy, Ruhi R.
Unde, Rohini R.
Namewar, Namrata P.
Kelkar, Devaki A.
Shashidhara, L. S.
Koppiker, Chaitanyanand B.
Kulkarni, Madhura D.
Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients
title Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients
title_full Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients
title_fullStr Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients
title_full_unstemmed Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients
title_short Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients
title_sort evaluation of tumor-infiltrating lymphocytes (tils) in molecular subtypes of an indian cohort of breast cancer patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677664/
https://www.ncbi.nlm.nih.gov/pubmed/36411483
http://dx.doi.org/10.1186/s13000-022-01271-y
work_keys_str_mv AT vaidpoojam evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients
AT puntambekaranirudhak evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients
AT jumlenutans evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients
AT banaleritujaa evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients
AT ansaridanish evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients
AT reddyruhir evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients
AT underohinir evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients
AT namewarnamratap evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients
AT kelkardevakia evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients
AT shashidharals evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients
AT koppikerchaitanyanandb evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients
AT kulkarnimadhurad evaluationoftumorinfiltratinglymphocytestilsinmolecularsubtypesofanindiancohortofbreastcancerpatients